ICU Medical

Youtube Subscribe

Open: 106.45 Close: 102.5 Change: -3.95

You're losing the opportunity of using an AI to get informed about ICU Medical.

The game is changing. There is a new strategy to evaluate ICU Medical fundamental value, possible risks and most salient advantages. Investors have traditionally relied in reading large amounts of text to evaluate the fundamental value of a stock or company. However, the development of Artificial Intelligence (AI) tools is modifying the way investments are evaluated in markets. Today, machine learning, natural language processing and bigdata allow making this process automatic, reducing large amounts of text to the elements that have a higher activation in a neural network. We programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about ICU Medical are: ICU, March, Medical, report, loss, revenue, US23b, …

Concept Map

Semantic Network

Stock Summary

ICU Medical, Inc. develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications. The company provides IV therapy and diluents, such as sodium chloride, dextrose, balanced.

Today's Summary

ICU Medical reported revenues of US$2.3b, in line with expectations, but unfortunately also reported (statutory) losses of US $1.23 per share, which were slightly larger than expected. The biggest low-light for us was that the forecasts for ICU medical dropped from profits to a loss. ICU Medical to Present at the Raymond James 45th Annual Institutional Investors Conference being held in Orlando, Florida, March 3-6, 2024. Company management will present at 4:30 a.m. on Monday, March 4, 2024 at. The presentation will be on March 4.

Today's News

ICU Medical reported revenues of US$2.3b, in line with expectations, but unfortunately also reported (statutory) losses of US $1.23 per share, which were slightly larger than expected. The biggest low-light for us was that the forecasts for ICU medical dropped from profits to a loss. ICU Medical to Present at the Raymond James 45th Annual Institutional Investors Conference being held in Orlando, Florida, March 3-6, 2024. Company management will present at 4:30 a.m. on Monday, March 4, 2024 at. The presentation will be on March 4.

Stock Profile

"ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; and ClearGuard HD, that maintains hemodialysis catheters. The company provides IV therapy and diluents, such as sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation solutions comprising sodium chloride and sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options. It offers infusion pumps under the Plum 360 brand; IV mediation safety software, including ICU Medical MedNet, an enterprise-class medication management platform that connects smart pumps to hospital's electronic health records, asset tracking systems, and alarm notification platforms; professional services; critical care products, such as Cogent 2-in-1 and CardioFlo hemodynamic monitoring systems; TDQ and OptiQ cardiac output monitoring catheters; TriOx venous oximetry catheters; Transpac blood pressure transducers; and SafeSet closed blood sampling and conservation systems. The company's customers include acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, including outpatient clinics, home health care providers, and long-term care facilities. ICU Medical, Inc. was founded in 1984 and is headquartered in San Clemente, California."

Keywords

This document will help you to evaluate ICU Medical without reading an infinite amount of sources. Relying only on stock quotes or prices to make investment decisions is a mistake. Analyzing and observing stock charts, highs and lows and other numerical data does not allow to evaluate the real value of a company. Stock quotes and prices are the result of underlying characteristics of a company and of events and news happening around them. For this reason, investing must be based on information, not numbers. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about ICU Medical are: ICU, March, Medical, report, loss, revenue, US23b, and the most common words in the summary are: care, medical, icu, health, stock, patient, service, . One of the sentences in the summary was: Company management will present at 4:30 a.m. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #care #medical #icu #health #stock #patient #service.

Read more →

Youtube Subscribe

---